Cooper Companies Inc
F:CP60
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cooper Companies Inc
F:CP60
|
US |
Intrinsic Value
The intrinsic value of 
Cooper Companies Inc (CP60) under the Base Case is 59.22 EUR per share.
Compared with the current market price of 53.32 EUR, the stock appears
Undervalued by 10% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Cooper Companies Does
Cooper Companies makes medical products in two main areas: contact lenses and women’s health. Through CooperVision, it sells soft contact lenses for nearsightedness, farsightedness, astigmatism, and presbyopia to eye doctors, optometrists, retailers, and patients. Through CooperSurgical, it sells tools and devices used by fertility clinics, hospitals, and other women’s health providers.
- Headquarters
- United States of America US
- Employees
- 15 000
- IPO date
- Jan 21, 1983
Cooper Companies has a narrow economic moat
Changing a successfully fitted contact lens takes extra clinical work and risks losing comfort or clear vision, which helps Cooper keep repeat customers. Approvals for specialized lenses also make it harder for new rivals to offer equivalent treatments without substantial testing and regulatory review.
Read the full moat analysis
Revenue & Expenses Breakdown
Cooper Companies Inc
Earnings Waterfall
Cooper Companies Inc
The intrinsic value for Cooper Companies Inc (CP60) under the Base Case is 59.22 EUR.
Compared with the current market price of 53.32 EUR, the stock appears Undervalued by 10% .